Barcelona, November 2025 – Catalonia.health hosted this November a working visit by the European consortium RISEMED4EU (Regional Innovation for Smart Ecosystems in Health and Medicine in the EU), an initiative bringing together eight regions from eight European countries with the aim of boosting innovation in health and personalised medicine through interregional collaboration and advanced technology

The technology centre Eurecat, a member of Catalonia.health, and the Catalan Institute of Oncology (ICO) have launched a pilot test of a digital platform based on artificial intelligence aimed at promoting healthy habits and emotional management in order to contribute to primary cancer prevention.  

The biopharmaceutical company Oniria Therapeutics, a member of Catalonia.health, is collaborating with the Vall d’Hebron Institute of Oncology (VHIO) and the Institute of Chemical Research of Catalonia (ICIQ) on the development of the innovative drug ONR-001, aimed at the treatment of treatment-resistant colorectal cancer.

The biopharmaceutical company Oryzon Genomics, a member of Catalonia.health, has presented new clinical data on iadademstat in patients with acute myeloid leukaemia (AML) at the 67thAnnual Meeting of the American Society of Hematology (ASH).

Integra Therapeutics, empresa biotecnològica especialitzada en tecnologia de redacció genètica d’última generació, membre de Catalonia.health, ha anunciat el nomenament de Miles Gerson com a president independent del seu Consell d’Administració.

The biopharmaceutical company Reig Jofre, a member of Catalonia.health, has announced the consolidation of its stake in Leanbio, a biotechnology company specialising in the development and production of biotechnological active pharmaceutical ingredients and also a member of Catalonia.health. 

The biotechnology start-up Nuage Therapeutics, a member of Catalonia.health, has secured €2.7 million in funding from the Spanish State Research Agency (AEI) of the Ministry of Science, Innovation and Universities

The Josep Carreras Leukaemia Research Institute, a member of Catalonia.health, is leading a new international alliance to accelerate the development of innovative diagnostic tools and therapeutic strategies for follicular lymphoma, one of the most common blood cancers.

mjn-neuro, a start-up specialising in neurotechnology applied to digital health and a member of Catalonia.health, and the European pharmaceutical group Neuraxpharm have announced plans to launch EPISERAS®

GoodGut, a biotechnology company specialising indigestive health solutions based on the intestinal microbiota and a member of Catalonia.health, is participating in a study being carried out at four primary care centres in the Girona Health Region to improve the diagnosis of irritable bowel syndrome.